发明名称 IMIDAZOPYRIMIDINE, IMIDAZOPYRAZINE AND IMIDAZOPYRIDAZINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR MODULATORS
摘要 The present invention relates to substituted imidazopyrimidine derivatives, substituted imidazopyrazine derivatives and substituted imidazopyridazine derivatives as melanocortin-4 receptor (MC-4R) modulators, in particular as melanocortin 4 receptor antagonists. The antagonists are useful for the treatment of disorders and diseases such as cachexia induced by e.g. cancer, chronic kidney disease (CKD) or chronic heart failure (CHF), muscle wasting, anorexia induced by e.g. chemotherapy or radiotherapy, anorexia nervosa, amyotrophic lateral sclerosis (ALS), pain, neuropathic pain, anxiety and depression, nausea and emesis. Formula (I).
申请公布号 CA2718558(A1) 申请公布日期 2009.09.24
申请号 CA20092718558 申请日期 2009.03.18
申请人 SANTHERA PHARMACEUTICALS (SCHWEIZ) AG 发明人 SOEBERDT, MICHAEL;DEPPE, HOLGER;ABEL, ULRICH;FEURER, ACHIM;METZ, GUNTHER;OTT, INGE;HOFFMANN-ENGER, BARBARA;NORDHOFF, SONJA
分类号 C07D487/04;A61K31/4985;A61K31/5025;A61K31/519;A61P1/00;A61P21/00;A61P35/00 主分类号 C07D487/04
代理机构 代理人
主权项
地址